![Erin Mitchell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Erin Mitchell
Corporate Officer/Principal en DNAtrix, Inc. .
Cargos activos de Erin Mitchell
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
Historial de carrera de Erin Mitchell
Antiguos cargos conocidos de Erin Mitchell.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Corporate Officer/Principal | - | - |
Formación de Erin Mitchell.
McMaster University | Undergraduate Degree |
University of Toronto | Graduate Degree |
University of Cambridge | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 3 |
Canadá | 3 |
Reino Unido | 2 |
Operativa
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectorial
Consumer Services | 4 |
Electronic Technology | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
DNAtrix, Inc.
![]() DNAtrix, Inc. Electronic Equipment/InstrumentsElectronic Technology DNAtrix, Inc. operates as a biotech company which focuses on the development of oncolytic viruses for cancer. The firm’s offers DNX-2401 product which is an oncolytic virus designed specifically for treating Glioblastoma. It also works to expand its platform technology for treating other cancers, including ovarian, prostate and pancreatic cancer indications. The company was founded in 2005 by Francis Patrick McCormick, Alfred Yung, Charles Conrad, Cande Gomez-Manzano and Juan Fueyo and is headquartered in Houston, TX. | Electronic Technology |
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Erin Mitchell
- Experiencia